IN THE NEWS: Dr. Nasim Afsar, chief operating officer for ambulatory care for UCI Health, is recognized as one of Orange County's leading women in healthcare by Coast Magazine and the Orange County Register. Afsar always knew that her life would be about providing health care to communities with the…
IN THE NEWS: Orange County companies, residents, students, alumni and philanthropists rally around UCI Health to help shore up supplies for the COVID-19 outbreak. When national health authorities sent out the first alerts in January about the novel coronavirus spreading in Wuhan, China, UCI Health administrators launched into action. They…
During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fold.
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A QandA with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
Orange, Calif. — UCI Health is initiating a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history…
Health Media Contacts
Find the best contact for health-related media inquiries.
